RxDoctor Payments Data

Benjamin Yourchock, MD

Family Medicine · Walkerton, INNPI 1730538414

Payments from drug & device makers

$448in general payments, 2019–2025

Across 23 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$116
  • Lilly USA, LLC$61
  • Inspire Medical Systems, Inc.$40
  • Supernus Pharmaceuticals, Inc.$40
  • Pfizer$34
  • Abbott$33
  • plus $124 from 7 others

What the payments were for

  • Food & beverage$448100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$448 in reported general payments places this provider in the 45th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$104,289
Medicare patients
213
Services billed
1,894

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide82$128,727
MounjaroTirzepatide80$111,801
JardianceEmpagliflozin61$73,900
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57$62,743
EliquisApixaban62$52,854
TrulicityDulaglutide25$43,080
Tresiba Flextouch U-100Insulin Degludec26$29,114
FarxigaDapagliflozin Propanediol24$22,998
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$17,365
Spiriva HandihalerTiotropium Bromide21$14,539
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr24$14,091
Combivent RespimatIpratropium/Albuterol Sulfate16$14,077
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt27$10,019
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$6,169
Novolog FlexpenInsulin Aspart17$5,852

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$61$154,881105 claims
Novo NordiskOzempic$116$128,72782 claims
PfizerEliquis, Paxlovid$34$54,28375 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$22$45,94858 claims
AbbVieSynthroid$22$2,32842 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Walkerton

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →